NCT00060710View on ClinicalTrials.gov

CP-461 in the Treatment of Patients With Advanced Melanoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

December 31, 2004

Conditions
Malignant Melanoma
Interventions
DRUG

CP-461

Trial Locations (1)

10032

Columbia Presbyterian Medical Center, New York

Sponsors
All Listed Sponsors
collaborator

Cell Pathways

INDUSTRY

collaborator

OSI Pharmaceuticals

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY